The 53rd Annual Meeting of Japan Society of Clinical Oncology
International Symposium
Thursday, October 29, 2015
International Session-1
“Collaborative Study on Gastric Cancer in Asia”
(1) Welcome Speech from Presidents
Masahiko Nishiyama (Japan Society of Clinical Oncology, JSCO)
Yi-Long Wu (Chinese Society of Clinical Oncology, CSCO)
Hyun Cheol Chung (Korean Association for Clinical Oncology, KACO)
(2) Keynote Lecture
Chair: Yi-Long Wu (Chinese Society of Clinical Oncology, CSCO)
Speaker: Kazuhiro Yoshida (Gifu University, Japan)
“Protocol for Asian Collaborative Study for Gastric Cancer”
(3) FACO Symposium-1 “Conversion Therapy for Stage IV Gastric Cancer: Multidisciplinary
Treatment Study in Asia”
Chair: Yuko Kitagawa (Japan Society of Clinical Oncology, JSCO)
Chair: Hyun Cheol Chung (Korean Association for Clinical Oncology, KACO)
Chair: Jin Li (Chinese Society of Clinical Oncology, CSCO)
Speaker
1. Kazuhiro Yoshida (Gifu University, Japan)
“New Category Classification and Conversion Therapy for Stage IV Gastric Cancer”
2. Ruihua Xu (Sun Yat-sen University Cancer Center, China)
“Recent Advancement of Chemotherapy for Advanced Gastric Cancer”
3. Jiafu Ji (Peking University of School of Oncology, China)
“Standard Perioperative Treatment of Gastric Cancer in Asia”
4. Sun Young Rha (Yonsei University College of Medicine, Korea)
“Different Biology and Therapeutic Management of Gastric Cancer between the East and the West”
5. Atsushi Ohtsu (National Cancer Center, Japan)
“Future Perspectives for Treatment of Metastatic and Recurrent Gastric Cancer”
6. Han Kwang Yang (Seoul National University, Korea)
“What to Act as a Surgical Oncologist in Asia for Gastric Cancer Patients”
International Session-2
“Precision Medicine in Gynecologic Oncology”
(1) Keynote Lecture
Chair: Hiroyuki Yoshikawa (President of JSGO, Japan)
Speaker: Jonathan A. Ledermann (University College London, UK)
“Personalization in Gynecologic Cancer Therapeutics: Future Perspective”
(2) Gynecologic Oncology Symposium
Chair: Michael J. Birrer (Massachusetts General Hospital, USA)
Chair: Joo-Hyun Nam (President of ASGO, Asan Medical Center, Korea)
Chair: David Cibula (Charles University, Czech Republic)
Speaker (Tentative):
1. Elise C. Kohn (National Cancer Institute, USA)
“Molecular Profiling and Ovarian Cancer Treatment; Where are we now?”
2. Noriomi Matsumura (Kyoto University, Japan)
“Whole Genome Sequencing of Ovarian Clear Cell Carcinoma: Clinical Implications”
3. Helen MacKay (Princess Margaret Hospital, University of Toronto, Canada)
“Intratumoral Genetic Heterogeneity of Ovarian Cancer”
4. Toyomi Sato (Tsukuba University, Japan)
“Fertility-sparing Surgery and Chemotherapy for Ovarian Cancer”
5. Takashi Onda (Kitasato University, Japan)
“Surgery after Neoadjuvant Chemotherapy for Advanced Ovarian Cancer”
6. Sang-Yoon Park (National Cancer Center, Korea)
“Surgery for Recurrent Ovarian Cancer: How to Select Patients?”
Friday, October 30, 2015
International Session-3
“Comprehensive Management of Hereditary Cancer”
(1) Welcome Speech from Presidents
Masahiko Nishiyama (Japan Society of Clinical Oncology, JSCO)
Peter P. Yu (American Society of Clinical Oncology, ASCO)
(2) Keynote Lecture
Chair: Seigo Nakamura (Japan Society of Clinical Oncology, JSCO)
Speaker: Noralane M. Lindor (Laboratory Medicine and Pathology, Mayo Clinic, USA)
“Genetic Counseling and Management for Hereditary Cancer Risk in USA”
(3) ASCO/JSCO Symposium
“Hereditary Cancer: Genetic Counseling, Diagnosis, and Risk-reducing Surgery”
Chair: Peter P. Yu (American Society of Clinical Oncology, ASCO)
Chair: Yoshimitsu Fukushima (Shinshu University, Japan)
Speaker (Tentative):
1. Seigo Nakamura (Department of Breast Surgery, Showa University)
“Japanese Guideline for Management of HBOC Family Members”
2. Fumio Takada (Kitasato University, Japan)
“Genetic Counseling and Tsting for HBOC Family Members in Japan”
3. David E. Cohn (The Ohio State University, USA)
“Prevention of Breast and Ovarian Cancer in HBOC Family Members”
4. Kristi Funk (Pink Lotus Breast Center, USA)
“Risk-reducing Breast Surgery for Woman with HBOC gene in USA”
5. Daisuke Aoki (Department of Obstetrics and Gynecology, Keio University)
”Endometrial Cancer in Women with Lynch Syndrome”
6. Kyoichi Takaori (Department of Surgery, Kyoto University, Japan)
“Familial Pancreatic Cancer Registration in Japan”
International Session-4
“Globalization of Precision Medicine in Oncology”
(1) Welcome Speech from Presidents
Masahiko Nishiyama (Japan Society of Clinical Oncology, JSCO)
Ralf A. Stahel (European Society for Medical Oncology, ESMO)
(2) Keynote Lecture
Chair: Yuko Kitagawa (Japan Society of Clinical Oncology, JSCO)
Speaker: Emile E. Voest (Executive Board of ESMO, Amsterdam, the Netherlands)
“Challenges and opportunities to implement genomics-guided personalized medicine”
(3) ESMO/JSCO Symposium “Toward Precision Medicine in Oncology”
Chair: Atsushi Ohtsu (National Cancer Center, Japan)
Chair: Ralf A. Stahel (European Society for Medical Oncology, ESMO)
Speaker (Tentative):
1. TBA
“Japan Contribution to International Cancer Genome Consortium (ICGC))”
2. Mitsuaki Kubo (Riken, Center for Genomic Medicine)
“Genome-wide Screening for Drug Sensitivity in Japanese Population”
3. TBA
“TBA”
4. Christophe Le Tourneau (Institut Curie, France)
“Frontier of Precision Medicine in Oncology: Progress of SHEVA Trial”
5. TBA
“TBA”
6. Takashi Kohno (NCC, Exploratory Oncology Research & Clinical Trial Center)
“Development of Novel Therapeutics using Synthetic Lethality”
International Session-5
“Come On! Young Oncologists and Medical Students!”
(1) Keynote Speech
Chair: Yoko Harima (Radiation Oncology, Kansai Medical University, Japan)
Speaker: Julie M. Vose (President Elect of ASCO, Nebraska Medical Center, USA)
“My Life and Academic Career”
(2) International Symposium for Young Doctors and Students
“Come on! Medical Students! Young Oncologists and Researchers! Enjoy our Science Life and Career
Path”
Chair: Peter P. Yu (President of ASCO)
Chair: Kinuko Mitani (Hematologic Oncology, Dokkyo Medical University, Japan)
Chair: Keiko Yamashita (Department of Breast Surgery, Hokkaido University, Japan)
Task Forces
1. Yael P. Mosse (Hematology, University of Pennsylvania, USA)
2. Kaoru Abiko (Gynecology and Obstetrics)
3. Momoko Nishikori (Hematology)
4. Hiroko Matsumoto (Gastrointestinal Medicine)
5. Megumi Takleuchi (Breast Surgery)
6. Motoko Hariya (Intestinal Surgery)
7. Nami Ueki (Radiation Oncology)
8. Yukiko Mori (Medical Oncology)
9. Seiko Yamawaki (Plastic Surgery)
10. Chiaki Suzuki (Head and Neck Surgery)
11. Rina Tanaka (Chest)
12. Aki Kido (Imaging Diagnosis)
13. Sachiko Minamiguchi (Pathology)
Saturday, October 31, 2015
International Session-6
“Advancement on Liver Cancer Management”
(1) Keynote Lecture
Chair: TBA
Speaker: Peter Naredi (President Elect of ECCO, University of Gothenburg, Sweden)
“Personalization of Surgery and Management for Hepatocellular Carcinoma”
(2) FACO Symposium-2 “Recent Development on Liver Cancer Treatment”
Chair: Shigeki Arii (Hamamatsu Rosai Hospital, JSCO)
Chair: Yi-Long Wu (Chinese Society of Clinical Oncology, CSCO)
Chair: Hyun Cheol Chung (Korean Association for Clinical Oncology, KACO)
Speaker (Tentative):
1. Pierce Chow (Duke-NUS Graduate Medical School Singapore, Singapore)
“Advancement of Basic and Clinical Research on Hepatocellular Carcinoma in Asia”
2. Naoya Kato (The Institute of Medical Science, The University of Tokyo, Japan)
“Genome-wide Study Reveals a Susceptibility Locus of Hepatocellular carcinoma”
3. Jong Young Choi (Kangnam St. Mary's Hospital, Catholic University of Korea, Korea)
“Multiple Gene Expression Profile of Liver Cancer: Integrative Analysis”
4. Etsuro Hatano (Department of Surgery, Kyoto University, Japan)
“Application New Imaging Modalities for Multidisciplinary Treatment of Advanced HCC”
5. Masatoshi Kudo (Gastroenterology and Hepatology, Kinki University, Japan)
“Molecular-targeted Therapy for Liver Cancer: Where are we now?”
6. Shukui Qin (Nanjing Jindu Hospital, China)
“Advancement of Surgical Treatment for Liver Cancer”